Mediterranean Diet and Parkinson's Disease

Int J Mol Sci. 2022 Dec 20;24(1):42. doi: 10.3390/ijms24010042.

Abstract

Parkinson's disease (PD) is an age-related neurodegenerative disorder, diagnosed on the basis of typical motor disturbances, but also characterized by the presence of non-motor symptoms, such as rapid eye movement (REM)-sleep behavior disorders, olfactory impairment, and constipation, which are often prodromal to the onset of the disease. PD is often associated with the presence of oxidative brain injury and chronic neuroinflammation, with infiltration and accumulation of peripheral immune cells that have been found in affected brain regions of PD patients. Recently, the role of the gut-brain axis in the pathogenesis of PD is getting more and more attention, and several pieces of evidence indicate alterations in the gut microbiota of PD-affected patients. Diet exerts a central role in defining the microbiota composition and different dietetic patterns can result in a higher or lower abundance of specific bacteria that, in turn, can affect gut permeability and express anti- or pro-inflammatory metabolites. In the present review, the effects of the Mediterranean diet in modulating both PD onset and its progression will be considered with a special focus on the antioxidant and anti-inflammatory properties of this dietetic regimen as well as on its effects on the microbiota composition.

Keywords: Mediterranean diet; Parkinson’s disease; gut-brain axis; olive oil; resveratrol.

Publication types

  • Review

MeSH terms

  • Brain / metabolism
  • Constipation / metabolism
  • Diet, Mediterranean*
  • Humans
  • Parkinson Disease* / metabolism
  • REM Sleep Behavior Disorder* / complications
  • REM Sleep Behavior Disorder* / metabolism
  • REM Sleep Behavior Disorder* / pathology

Grants and funding

This research received no external funding.